AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ELI LILLY & Co Director's Dealing 2015

Feb 9, 2015

29745_dirs_2015-02-09_051541c6-7fcd-4445-a6af-95d7c5665209.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Zosano Pharma Corp (ZSAN)
CIK: 0001587221
Period of Report: 2015-01-30

Reporting Person: LILLY ELI & CO (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1363636	Direct